Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00926211 · ClinicalTrials.gov registry record · NA

Computer-Assisted Versus Manual Hair Harvest Comparative Study

A NA study of Androgenetic Alopecia, sponsored by Restoration Robotics.

Completed
Registry status
NA
Development phase
37
Enrollment target
2
Study locations

NCT00926211: Completed NA study of Androgenetic Alopecia, sponsored by Restoration Robotics.

NCT00926211 is a NA study of Androgenetic Alopecia that has completed, run by Restoration Robotics. The registered enrollment target is 37 participants, below the 163-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00926211, a NA study of Androgenetic Alopecia, has completed, sponsored by Restoration Robotics.

COMPLETED
Registry status
NA
Development phase
37 participants
Enrollment target
2
Study locations

Study Summary

The objective of this clinical study is to investigate and compare the safety and efficacy of the Restoration Robotics Computer-Assisted Harvesting System to the manual hair follicle harvesting method following a nine-month period of post-procedural evaluation.

Primary Outcome

The increase in the number of hair follicles present at follow-up in each region compared to the number present at baseline.

Conditions Studied

Interventions

  • DEVICE ARTAS™ System
  • PROCEDURE Manual Hair Harvest

Study Locations (2)

California

  • Berman Skin Institute - Palo Alto
  • A Practice of Hair Restoration - Walnut Creek

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2009-06
Est. Completion 2010-09
Phase NA
Restoration Robotics

1 total trials

What the finished NCT00926211 record still lists

NCT00926211 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 37 participants, a relatively small participant target, below the 163-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (77% lower).

The record links to 1 condition, with Androgenetic Alopecia appearing as the primary indexed condition, and to 2 interventions - of which ARTAS™ System is the first listed.

NCT00926211 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00926211 about?

NCT00926211 is a clinical study titled "Computer-Assisted Versus Manual Hair Harvest Comparative Study". The objective of this clinical study is to investigate and compare the safety and efficacy of the Restoration Robotics Computer-Assisted Harvesting System to the manual hair follicle harvesting method following a nine-month period of post-procedural evaluation.

What is the current status of trial NCT00926211?

This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2009-06. Estimated completion is 2010-09.

What conditions does trial NCT00926211 study?

This clinical trial studies the following conditions: Androgenetic Alopecia.

What interventions are being tested in trial NCT00926211?

The interventions under investigation include: ARTAS™ System (DEVICE), Manual Hair Harvest (PROCEDURE).

Who is sponsoring clinical trial NCT00926211?

This trial is sponsored by Restoration Robotics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00926211 being conducted?

This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Androgenetic Alopecia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00926211's enrollment target sits among peer trials

37 11th of 16 higher than 6 of 16 other Androgenetic Alopecia trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Androgenetic Alopecia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02800486 · 37 participants · Phase 2

    Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA

  • NCT03173937 · 37 participants · Phase 1

    Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome

  • NCT03295227 · 37 participants · Phase 1

    Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer

  • NCT03401047 · 37 participants · Early Phase 1

    Study to Assess Potential Impairments in Estradiol Augmentation of Gonadotropin Secretion in Polycystic Ovary Syndrome

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00926211, the US trial registry maintained by the National Library of Medicine. NCT00926211 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.